Dr Friedenreich’s presentation will cover research into the ComPARe study, a five-year long project that examined the proportion of cancers that were attributable to modifiable cancer risk factors in Canada for 2015 and the number of cancers that could be avoided up to 2042 if exposures to these risk factors were reduced.
Dr Friedenreich holds a doctorate in Epidemiology from the University of Toronto and completed postdoctoral training at the International Agency for Research on Cancer and the University of Calgary. She is a cancer epidemiologist who has been studying the role of physical activity in reducing cancer risk, improving rehabilitation and survival after cancer diagnosis for nearly three decades. She has conducted over 40 observational epidemiologic and randomized controlled intervention trials in this area. She is the Scientific Director for the Department of Cancer Epidemiology and Prevention Research for Alberta Health Services, the Division Head and Adjunct Professor for Preventive Oncology, Cumming School of Medicine, University of Calgary and an Adjunct Professor in the Department of Community Health Sciences and the Faculty of Kinesiology at the U of C. She is also the Associate Scientific Director for the O’Brien Institute of Public Health at the Cumming School of Medicine. Dr Friedenreich has held numerous career awards from national and provincial health funding agencies and was awarded the Canadian Cancer Society’s O. Harold Warwick Prize (2013), named a fellow of the Canadian Academy of Health Sciences (2016) and will be inducted as a Fellow into the Royal Society of Canada in November, 2019.
Can't attend in person? Register for Webinar
